Patents by Inventor Ching-Cheng Wang

Ching-Cheng Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
    Patent number: 7119094
    Abstract: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: October 10, 2006
    Assignee: Warner-Lambert Company
    Inventors: Michael S. South, John J. Parlow, Darin E. Jones, Brenda Case, Tom Dice, Richard Lindmark, Michael J. Hayes, Melvin L. Rueppel, Rick Fenton, Gary W. Franklin, Horng-Chih Huang, Wei Huang, Carrie Kusturin, Scott A. Long, William L. Neumann, David B. Reitz, John I. Trujillo, Ching-Cheng Wang, Rhonda Wood, Qingping Zeng, Matthew W. Mahoney
  • Mold and slide block thereof
    Publication number: 20060219380
    Abstract: A slide block comprises a body, a block core and a fastener. The body comprises an angular hole formed on a first body surface thereof. The block core is detachably fixed on the body. The block core comprises a first core surface and a mold pattern, and the mold pattern is formed on the first core surface. The fastener detachably connects the block core to the body.
    Type: Application
    Filed: October 21, 2005
    Publication date: October 5, 2006
    Inventors: Ching-Cheng Wang, Jung-Wen Chang, Chao-Hung Lin
  • Mouse
    Publication number: 20060181512
    Abstract: A mouse comprises a body and a supportive housing. The supportive housing is disposed on the body and shifted between a first position and a second position, wherein when the supportive housing is in the first position, the supportive housing contacts and supports the palm of a user.
    Type: Application
    Filed: September 26, 2005
    Publication date: August 17, 2006
    Inventors: Ching-Cheng Wang, Jung-Wen Chang
  • Method for connection between composite material and fixing element and structure thereof
    Publication number: 20060099378
    Abstract: A method for connection between composite material and the step of method between composite material comprises (a) gluing a fixing element to a mold and generating a gap between the fixing element and the mold, (b) filling a liquid epoxy in the gap, (c) contacting a composite material with the fixing element and the liquid epoxy simultaneously, (d) solidifying the liquid epoxy, and (e) separating the mold from the fixing element. Connection structure between composite materials comprises a fixing element, an epoxy, and a composite material. The fixing element comprises a first contact surface. The composite material comprises a second contact surface. The first and the second connect surface connecting each other via the epoxy are not adhered by the epoxy.
    Type: Application
    Filed: May 27, 2005
    Publication date: May 11, 2006
    Inventors: Ching-Cheng Wang, Chao-Hung Lin, Jung-Wen Chang
  • Protease inhibitors
    Publication number: 20050143320
    Abstract: This invention relates to treating an infection with a virus using protease inhibitors. Examples of the protease inhibitors include compounds of formula (II). Each variable is defined in the specification.
    Type: Application
    Filed: February 25, 2005
    Publication date: June 30, 2005
    Inventors: Syaulan Yang, Jen-Dar Wu, Feng-Yih Su, Chun-Wei Kuo, Wen-Chang Chen, Ming-Chu Hsu, Yibin Xiang, Ching-Cheng Wang, Shao-Ying Liao
  • Protease inhibitors
    Publication number: 20050143319
    Abstract: This invention relates to treating an infection with a virus using protease inhibitors. Examples of the protease inhibitors include compounds of formula (I). Each variable is defined in the specification.
    Type: Application
    Filed: December 29, 2004
    Publication date: June 30, 2005
    Inventors: Syaulan Yang, Jen-Dar Wu, Feng-Yih Su, Chun-Wei Kuo, Wen-Chang Chen, Yibin Xiang, Ching-Cheng Wang, Shao-Ying Liao
  • Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
    Patent number: 6908919
    Abstract: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: June 21, 2005
    Assignee: Pharmacia Corporation
    Inventors: Michael S. South, Brenda L. Case, Thomas A. Dice, Ricky L. Fenton, Gary W. Franklin, Michael J. Hayes, Horng-Chih Huang, Wei Huang, Darin E. Jones, Carrie L. Kusturin, Richard J. Lindmark, Scott A. Long, William L. Neumann, David B. Reitz, John I. Trujillo, Ching-Cheng Wang, Rhonda Wood, Qingping Zeng, Matthew W. Mahoney, John J. Parlow, Melvin L. Rueppel
  • Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
    Patent number: 6875877
    Abstract: A process for preparing enantiomerically enriched tetrahydrobenzothipeine oxides comprises cyclizing an enantiomerically enriched aryl-3-propanalsulfoxide wherein the sulfur atom of the aryl-3-propanalsulfoxide is a chiral center.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: April 5, 2005
    Inventors: Jinglin (James T.) Li, Ching-Cheng Wang, David B. Reitz, Victor Snieckus, Horng-Chih Huang, Andrew J. Carpenter
  • Polyamine compounds for treating chemokine receptor mediated diseases
    Publication number: 20050043366
    Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
    Type: Application
    Filed: March 30, 2004
    Publication date: February 24, 2005
    Inventors: Kak-Shan Shia, Gholam Hakimelahi, Jia-Liang Zhu, Chi-Feng Yen, Ying-Huey Huang, Yibin Xiang, Hua-Chien Chen, Ching-Cheng Wang
  • Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
    Publication number: 20050043313
    Abstract: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
    Type: Application
    Filed: September 14, 2004
    Publication date: February 24, 2005
    Inventors: Michael South, Brenda Case, Thomas Dice, Ricky Fenton, Gary Franklin, Michael Hayes, Horng-Chih Huang, Wei Huang, Darin Jones, Carrie Kusturin, Richard Lindmark, Scott Long, William Neumann, David Reitz, John Trujillo, Ching-Cheng Wang, Rhonda Wood, Qingping Zeng, Matthew Mahoney, John Parlow, Melvin Rueppel
  • Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
    Publication number: 20040102448
    Abstract: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of dirombotic conditions including coronary artery and cerebrovascular diseases.
    Type: Application
    Filed: October 23, 2003
    Publication date: May 27, 2004
    Applicant: Pharmacia Corporation
    Inventors: Michael S. South, John J. Parlow, Darin E. Jones, Brenda Case, Tom Dice, Richard Lindmark, Michael J. Hayes, Melvin L. Rueppel, Horng-Chih Huang, Wei Huang, Scott A. Long, Matthew W. Mahoney, William L. Neumann, David B. Reitz, John I. Trujillo, Ching-Cheng Wang, Rhonda Wood, Qingping Zeng, Rick Fenton, Gary W. Franklin, Carrie Kusturin
  • Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
    Publication number: 20040006230
    Abstract: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
    Type: Application
    Filed: July 15, 2002
    Publication date: January 8, 2004
    Applicant: Pharmacia Corporation
    Inventors: Michael S. South, Brenda L. Case, Thomas A. Dice, Ricky L. Fenton, Gary W. Franklin, Michael J. Hayes, Horng-Chih Huang, Wei Huang, Darin E. Jones, Carrie L. Kusturin, Richard J. Lindmark, Scott A. Long, William L. Neumann, David B. Reitz, John I. Trujillo, Ching-Cheng Wang, Rhonda Wood, Qingping Zeng, Matthew W. Mahoney, John J. Parlow, Melvin L. Rueppel
  • Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
    Patent number: 6664255
    Abstract: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
    Type: Grant
    Filed: May 18, 2000
    Date of Patent: December 16, 2003
    Assignee: Pharmacia Corporation
    Inventors: Michael South, John J. Parlow, Darin E. Jones, Brenda Case, Tom Dice, Richard Lindmark, Michael J. Hayes, Melvin L. Rueppel, Horng-Chih Huang, Wei Huang, Scott A. Long, Matthew Mahoney, William L. Neumann, David Reitz, John I. Trujillo, Ching-Cheng Wang, Rhonda Wood, Qingping Zeng, Rick Fenton, Gary W. Franklin, Carrie Kusturin
  • Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
    Publication number: 20020188119
    Abstract: A process for preparing enantiomerically enriched tetrahydrobenzothipeine oxides comprises cyclizing an enantiomerically enriched aryl-3-propanalsulfoxide wherein the sulfur atom of the aryl-3-propanalsulfoxide is a chiral center.
    Type: Application
    Filed: February 11, 2002
    Publication date: December 12, 2002
    Inventors: Jinglin Li, Ching-Cheng Wang, David B. Reitz, Victor Snieckus, Horng-Chih Huang, Andrew J. Carpenter
  • Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
    Patent number: 6369220
    Abstract: A process for preparing enantiomerically enriched tetrahydrobenzothipeine oxides comprises cyclizing an enantiomerically enriched aryl-3-propanalsulfoxide wherein the sulfur atom of the aryl-3-propanalsulfoxide is a chiral center.
    Type: Grant
    Filed: October 2, 2000
    Date of Patent: April 9, 2002
    Inventors: Jinglin (James T.) Li, Ching-Cheng Wang, David B. Reitz, Victor Snieckus, Horng-Chih Huang, Andrew J. Carpenter